leflunomide has been researched along with mocetinostat in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Arshad, F; Bailey, SC; Kurtz, ES; Lee, AA; Przekop, PA | 1 |
| Fadillioglu, E; Gursul, C; Karaman, A; Tas, E; Turkmen, E | 1 |
| Cecen, S; Demir, EM; Ergin, K; Kose, H; Serter, M; Yildiz, Y | 1 |
| Kaptanoglu, B; Kutluana, U; Nart, D; Oruc, N; Ozutemiz, O; Yonetci, N | 1 |
| Demircan, M; Fadillioglu, E; Gülsul, C; Karadag, N; Karaman, A; Kirimlioglu, H; Tas, E | 1 |
| Sun, L; Tan, W; Wang, H | 1 |
7 other study(ies) available for leflunomide and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Leflunomide: an active antiinflammatory and antiproliferative agent in models of dermatologic disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bromodeoxyuridine; Cell Division; Chronic Disease; Edema; Humans; Isoxazoles; Leflunomide; Leukotriene B4; Male; Mice; Mice, Inbred Strains; Neutral Red; Peroxidase; Phorbol Esters; Skin Diseases | 1995 |
Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Blood Urea Nitrogen; Catalase; Creatinine; Female; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lipid Peroxidation; Nitric Oxide; Oxidative Stress; Peroxidase; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Xanthine Oxidase | 2006 |
Protective effects of leflunomide on intestinal ischemia-reperfusion injury: leflunomide against intestinal ischemia-reperfusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Intestinal Diseases; Intestinal Mucosa; Isoxazoles; Leflunomide; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Treatment Outcome | 2010 |
Leflunomide: is a new oral agent in treatment of acute pancreatitis?
Topics: Administration, Oral; Amylases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Isoxazoles; Leflunomide; Male; Malondialdehyde; Neutrophil Infiltration; Nitric Oxide; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Pulmonary Edema; Rats; Rats, Wistar; Severity of Illness Index; Taurocholic Acid | 2010 |
Effect of leflunomide on liver regeneration after partial hepatectomy in rats.
Topics: Adjuvants, Immunologic; Animals; Catalase; Disease Models, Animal; Hepatectomy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver; Liver Diseases; Liver Regeneration; Malondialdehyde; Nitric Oxide; Oxidative Stress; Peroxidase; Protein Carbonylation; Rats; Rats, Wistar; Treatment Outcome | 2010 |
Clinical features of children with pulmonary microscopic polyangiitis: report of 9 cases.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Child; Child, Preschool; Complement C3; Cough; Cyclophosphamide; Female; Hematuria; Hemoptysis; Humans; Immunosuppressive Agents; Infant; Isoxazoles; Kidney; Leflunomide; Lung; Male; Microscopic Polyangiitis; Peroxidase; Proteinuria; Steroids; Tachypnea; Treatment Outcome | 2015 |